ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Hongcheng Wang
Matched on ORCID iD 0000-0003-3544-2039; OpenAlex author ID A5101753503. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 10
- Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer. Co-author DOI 10.1186/s12935-024-03410-5↗
- CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-3… Co-author PMID 38058810↗
- Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Co-author DOI 10.1016/j.cellsig.2022.110282↗
- Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Co-author DOI 10.1038/s41598-020-64068-3↗
- Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pancreatic cancer cells. First author DOI 10.1016/j.jep.2019.02.005↗
- Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasing the accumulation of reactive oxygen s… Co-author DOI 10.1186/s12935-018-0705-x↗
- Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). First author DOI 10.1186/s13046-017-0579-0↗
- Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. Co-author DOI 10.5301/tj.5000240↗
- Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. First author PMID 26175941↗
- Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway. First author DOI 10.5754/hge11476↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xinyu Huang · 8 shared papers, 2012–2023 · strength 0.86
- Paper CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic duc… PMID 38058810↗
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Guanggai Xia · 5 shared papers, 2017–2024 · strength 0.78
- Paper Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes effi… DOI 10.1186/s12935-024-03410-5↗
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Yiwei Wang · 2 shared papers, 2022–2024 · strength 0.47
- Paper Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes effi… DOI 10.1186/s12935-024-03410-5↗
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Jiazhe Liu · 3 shared papers, 2019–2022 · strength 0.42
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Paper Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pan… DOI 10.1016/j.jep.2019.02.005↗
- Zhou Yuan · 3 shared papers, 2015–2023 · strength 0.32
- Paper CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic duc… PMID 38058810↗
- Paper Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. DOI 10.5301/tj.5000240↗
- Paper Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. PMID 26175941↗
- Xiu−Yan Huang · 3 shared papers, 2017–2020 · strength 0.31
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Paper Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasi… DOI 10.1186/s12935-018-0705-x↗
- Paper Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reducta… DOI 10.1186/s13046-017-0579-0↗
- Xinyu Huang · 1 shared paper, 2024 · strength 0.28
- Xiongzhi Wangpu · 1 shared paper, 2023 · strength 0.20
- Qingcai Meng · 3 shared papers, 2015–2017 · strength 0.19
- Paper Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reducta… DOI 10.1186/s13046-017-0579-0↗
- Paper Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. DOI 10.5301/tj.5000240↗
- Paper Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. PMID 26175941↗
- Xubo Wu · 1 shared paper, 2019 · strength 0.10
- Jian Jun Huang · 1 shared paper, 2012 · strength 0.04
- Qi Zheng · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.